Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
about
sameAs
Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathologyCoordinated gene expression during gilthead sea bream skeletogenesis and its disruption by nutritional hypervitaminosis AA common variant in fibroblast growth factor binding protein 1 (FGFBP1) is associated with bone mineral density and influences gene expression in vitroGlobal expression profiling reveals genetic programs underlying the developmental divergence between mouse and human embryogenesis.Stem cells and the formation of the myocardium in the vertebrate embryo.A computational analysis of bone formation in the cranial vault in the mouseGene expression profile in mesenchymal stem cells derived from dental tissues and bone marrow.Gene expression changes between patent and fused cranial sutures in a nonsyndromic craniosynostosis populationEnhanced Activation of Canonical Wnt Signaling Confers Mesoderm-Derived Parietal Bone with Similar Osteogenic and Skeletal Healing Capacity to Neural Crest-Derived Frontal Bone.Closing the Gap: Genetic and Genomic Continuum from Syndromic to Nonsyndromic Craniosynostoses.The Effect of Covalently Immobilized FGF-2 on Biphasic Calcium Phosphate Bone Substitute on Enhanced Biological Compatibility and ActivityNanoplex-Mediated Codelivery of Fibroblast Growth Factor and Bone Morphogenetic Protein Genes Promotes Osteogenesis in Human Adipocyte-Derived Mesenchymal Stem Cells.ALX4 gain-of-function mutations in nonsyndromic craniosynostosisAugmentation of Smad-dependent BMP signaling in neural crest cells causes craniosynostosis in mice.Bone morphogenetic protein-2: a potential regulator in scleral remodeling.c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis.FAD104, a regulatory factor of adipogenesis, acts as a novel regulator of calvarial bone formation.The molecular and cellular basis of Apert syndrome.Fibroblast growth factor (FGF) signaling in development and skeletal diseases.A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.A Fusion between Domains of the Human Bone Morphogenetic Protein-2 and Maize 27 kD γ-Zein Accumulates to High Levels in the Endoplasmic Reticulum without Forming Protein Bodies in Transgenic Tobacco.BMP4 promotes prostate tumor growth in bone through osteogenesis.Unique modulation of cadherin expression pattern during posterior frontal cranial suture development and closure.Regeneration of bone using nanoplex delivery of FGF-2 and BMP-2 genes in diaphyseal long bone radial defects in a diabetic rabbit model.Bone morphogenetic protein is required for fibroblast growth factor 2-dependent later-stage osteoblastic differentiation in cranial suture cells.A MULTISCALE COMPUTATIONAL MODEL FOR THE GROWTH OF THE CRANIAL VAULT IN CRANIOSYNOSTOSIS
P2860
Q28585125-62AB9BD2-05C4-4A6A-8933-B3924D031C25Q33816325-D9B9A8CF-B759-4981-B8A2-EFADE7D834DFQ33987585-22108282-F4A5-4136-926D-9CB67433E6B2Q34958453-AE5BEE44-F7F6-40F9-9BE0-F4C4FF0C71C1Q34985684-17DAA7B8-2D93-4F62-9BF2-F7B9AFC38AA5Q35193948-F4E4C2F3-86AE-4734-87F9-6299867CE66FQ35219608-CCB3EFB1-9FA3-4747-8E3B-B4F894CB7457Q35468381-2AD6B371-ED1D-4EDA-99BA-B695077C261DQ35797425-B4466B09-2858-42CE-B76F-40F152627E15Q35809894-FCEA026C-96A3-497E-ACD3-4CECC6D7C4A1Q36075712-BC493B8C-A767-4A5A-8028-71941E6E33AAQ36185566-FDAA0A87-5962-4545-A592-415ABA36F61DQ36392637-6147ACD1-95E4-4D1B-B1A9-DD65C3F9253EQ36800176-D272B3EE-FC8E-48E5-A38B-DB172E50415FQ37020142-8ACC0428-0FE1-4A46-8F9B-7422A51162B4Q37112666-F1C877C5-CA51-40FB-81AD-EF76A55DBE57Q37272149-A70C2FA5-564B-4EDD-938C-1E8763958C7EQ38262522-4CE6ABD7-574D-41A9-8486-3005BE50AF74Q38354513-B58DBBDC-9430-4963-B1FF-DE3C99930085Q38726586-D148F394-7590-40EA-9AF8-11B7428F55A9Q39426330-2AD62B70-6ED7-4008-A0FD-A67663AC857BQ39525268-F251A8DC-C298-4CC0-AEED-48A8B50C9D7DQ40177791-AD617433-7586-425B-80DF-7EFAF6E18330Q40388484-60BF7B3A-B9C8-4320-A6C3-3BB13E62C397Q40867214-A3C77619-4191-4832-9B41-34AD600522D2Q56266847-A89654AF-7FEE-427C-A330-5953046AC234
P2860
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
description
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Jahr 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2002)
@en
vedecký článok (publikovaný 2002)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002)
@nl
наукова стаття, опублікована у 2002
@uk
مقالة علمية (نشرت عام 2002)
@ar
name
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@ast
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@en
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@nl
type
label
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@ast
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@en
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@nl
prefLabel
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@ast
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@en
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@nl
P2093
P356
P1476
Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling
@en
P2093
P304
P356
10.14670/HH-17.877
P407
P577
2002-01-01T00:00:00Z